scholarly journals A Phase I Study of Daily Afatinib, an Irreversible Erbb Family Blocker, Combined With Weekly Paclitaxel and 2-Weekly Bevacizumab in Patients with Advanced Solid Tumours

2012 ◽  
Vol 23 ◽  
pp. ix161
Author(s):  
D. Enting ◽  
J.E. Ang ◽  
C. O'Hanlon-Brown ◽  
R. Kristeleit ◽  
M. Uttenreuther-Fischer ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Solid Tumours ◽  
Weekly Paclitaxel ◽  
Erbb Family ◽  
Erbb Family Blocker

Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours

2008 ◽  
Vol 44 (13) ◽  
pp. 1829-1834 ◽  
Author(s):  
S. Cresta ◽  
C. Sessa ◽  
C.V. Catapano ◽  
E. Gallerani ◽  
D. Passalacqua ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Solid Tumours ◽  
Weekly Paclitaxel

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours

2001 ◽  
Vol 37 ◽  
pp. S75
Author(s):  
N. Androulakis ◽  
Ch. Kouroussis ◽  
D. Mavroudis ◽  
S. Agelaki ◽  
J. Souglakos ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Solid Tumours ◽  
Weekly Paclitaxel

Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours

2002 ◽  
Vol 38 (15) ◽  
pp. 1992-1997 ◽  
Author(s):  
N Androulakis ◽  
C Kouroussis ◽  
D Mavroudis ◽  
S Kakolyris ◽  
J Souglakos ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Solid Tumours ◽  
Weekly Paclitaxel

Intravenous administration of CP-4055 (ELACYT™) in patients with solid tumours. A phase I study

2009 ◽  
Vol 48 (1) ◽  
pp. 137-145 ◽  
Author(s):  
Svein Dueland ◽  
Steinar Aamdal ◽  
Michael J. Lind ◽  
Hilary Thomas ◽  
Marit Liland Sandvold ◽  
...  
Keyword(s):  
Phase I ◽  
Intravenous Administration ◽  
Phase I Study ◽  
Solid Tumours
Sign in / Sign up

Export Citation Format

Share Document